GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chongqing Lummy Pharmaceutical (SZSE:300006) » Definitions » 3-Year Book Growth Rate

Chongqing Lummy Pharmaceutical (SZSE:300006) 3-Year Book Growth Rate : 11.00% (As of Sep. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Chongqing Lummy Pharmaceutical 3-Year Book Growth Rate?

Chongqing Lummy Pharmaceutical's Book Value per Share for the quarter that ended in Sep. 2024 was ¥1.95.

During the past 12 months, Chongqing Lummy Pharmaceutical's average Book Value per Share Growth Rate was -0.80% per year. During the past 3 years, the average Book Value per Share Growth Rate was 11.00% per year. During the past 5 years, the average Book Value per Share Growth Rate was 0.60% per year. During the past 10 years, the average Book Value per Share Growth Rate was 1.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Chongqing Lummy Pharmaceutical was 50.30% per year. The lowest was -11.50% per year. And the median was 11.00% per year.


Competitive Comparison of Chongqing Lummy Pharmaceutical's 3-Year Book Growth Rate

For the Drug Manufacturers - General subindustry, Chongqing Lummy Pharmaceutical's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chongqing Lummy Pharmaceutical's 3-Year Book Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chongqing Lummy Pharmaceutical's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Chongqing Lummy Pharmaceutical's 3-Year Book Growth Rate falls into.



Chongqing Lummy Pharmaceutical 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.


Chongqing Lummy Pharmaceutical  (SZSE:300006) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.


Chongqing Lummy Pharmaceutical 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Chongqing Lummy Pharmaceutical's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Chongqing Lummy Pharmaceutical Business Description

Traded in Other Exchanges
N/A
Address
99 Yuma Road, Nan'an District, chongqing, CHN, 401123
Chongqing Lummy Pharmaceutical is a wholly-owned subsidiary of Lai America Pharmaceutical Co., Ltd. and is a professional pharmaceutical sales company in China.
Executives
Lai Wen Executives
Yuan Yuan Supervisors
Qiu Yu Directors, executives
Leng Xue Feng Secretary, Director
Zhang Xiao Xue Supervisors
Wang Ying Director
Zhou Xue Mei Supervisors
Zhao Bin Executives
Tang Xiao Hai Executives
Fu Rong Executives
Li Xian Feng Supervisors
Qiu Wei Director

Chongqing Lummy Pharmaceutical Headlines

No Headlines